In real-world clinical practice current status of refractory with topical antifungal drug therapy on onychomycosis and efficacy and safety of fosravuconazole switching treatment: a retrospective study - Trial UMIN000048054
Access comprehensive clinical trial information for UMIN000048054 through Pure Global AI's free database. This Not Applicable trial is sponsored by Sato Pharmaceutical Co., Ltd and is currently Recruiting. The study focuses on Onychomycosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000048054
Not Applicable
Recruiting
Trial Details
University Hospital Medical Information Network โข UMIN000048054
In real-world clinical practice current status of refractory with topical antifungal drug therapy on onychomycosis and efficacy and safety of fosravuconazole switching treatment: a retrospective study
Study Focus
Observational
Sponsor & Location
Sato Pharmaceutical Co., Ltd
Japan
Timeline & Enrollment
Not Applicable
Mar 29, 2022
N/A
ICD-10 Classifications
Onychogryphosis
Chromomycosis, unspecified
Onycholysis
Actinomycosis
Blastomycosis
Data Source
University Hospital Medical Information Network
UMIN000048054
Non-Device Trial

